Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Anneleen Beckers

No current affiliation with UGent

Add to list
- Journal Article
- A1
- open access
Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma

Lei Zhai, Anushree Balachandran, Rebecca Larkin, Janith A. Seneviratne, Sylvia A. Chung, Amit Lalwani, Shoma Tsubota, Dominik Beck, Kenji Kadomatsu, Anneleen Beckers (UGent) , et al.

(2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(21).
Add to list
- Journal Article
- A1
- open access
MEIS2 is an adrenergic core regulatory transcription factor involved in early initiation of TH-MYCN-driven neuroblastoma formation

Jolien De Wyn, Mark W. Zimmerman, Nina Weichert-Leahey, Carolina de Carvalho Nunes (UGent) , Belamy B. Cheung, Brian J. Abraham, Anneleen Beckers (UGent) , Pieter-Jan Volders (UGent) , Bieke Decaesteker (UGent) , Daniel R. Carter, et al.

(2021) CANCERS. 13(19).
Add to list
Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN

Chi Yan Ooi, Daniel R Carter, Bing Liu, Chelsea Mayoh, Anneleen Beckers (UGent) , Amit Lalwani, Zsuzsanna Nagy, Sara De Brouwer (UGent) , Bieke Decaesteker (UGent) , Tzong-Tyng Hung, et al.

(2018) CANCER RESEARCH. 78(12). p.3122-3034
Add to list
- Journal Article
- A2
- open access
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease

Bram De Wilde (UGent) , Anneleen Beckers (UGent) , Sven Lindner, Kristina Althoff, Katleen De Preter (UGent) , Pauline Depuydt, Pieter Mestdagh (UGent) , Tom Sante (UGent) , Steve Lefever (UGent) , Falk Hertwig, et al.

(2018) ONCOTARGET. 9(9). p.8334-8349
Add to list
- Journal Article
- A1
- open access
Targeting tachykinin receptors in neuroblastoma

Anton G Henssen, Andrea Odersky, Annabell Szymansky, Marleen Seiler, Kristina Althoff, Anneleen Beckers (UGent) , Franki Speleman (UGent) , Simon Schäfers, Katleen De Preter (UGent) , Kathy Astrahanseff, et al.

(2017) ONCOTARGET. 8(1). p.430-443
Add to list
- Conference Paper
- C3
The chromosome 17q super-enhancer landscape in neuroblastoma

Bieke Decaesteker (UGent) , Anton Henssen, Wouter Van Loocke (UGent) , Francisco Avila Cobos (UGent) , Anneleen Beckers (UGent) , Stein Aerts, Johannes Schulte, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2016) Enhancer Malfunction in Cancer, Keystone symposium, Abstracts.
Add to list
- Conference Paper
- C3
The TBX2 super-enhancer marked transcription factor on 17q is overexpressed in neuroblastoma and infers poor prognosis

Bieke Decaesteker (UGent) , Fanny De Vloed (UGent) , Siebe Loontiens (UGent) , Geertrui Denecker (UGent) , Wouter Van Loocke (UGent) , Moritz Gartlgruber, Dries Rombaut, Anneleen Beckers (UGent) , Shana Claeys (UGent) , Anton Henssen, et al.

(2016) Light on the Dark Side of the Genome, Abstracts.
Add to list
- Conference Paper
- C3
SOX11 acts as part of the MYCN regulatory protein complex implicated in neuroblastoma

Bieke Decaesteker (UGent) , Sara De Brouwer (UGent) , Suzanne Vanhauwaert (UGent) , Fanny De Vloed (UGent) , Anneleen Beckers (UGent) , Genevieve Laureys (UGent) , Stein Aerts, Sara Ek, Franki Speleman (UGent) and Katleen De Preter (UGent)

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Conference Paper
- C3
The TBX2 super-enhancer marked transcription factor on 17q is overexpressed in neuroblastoma and infers poor prognosis

Bieke Decaesteker (UGent) , Anton Henssen, Wouter Van Loocke (UGent) , Anneleen Beckers (UGent) , Siebe Loontiens (UGent) , Johannes Schulte, Katleen De Preter (UGent) and Franki Speleman (UGent)

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Journal Article
- A1
- open access
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

Johannes Fabian, Desirée Opitz, Kristina Althoff, Marco Lodrini, Barbara Hero, Ruth Volland, Anneleen Beckers (UGent) , Katleen De Preter (UGent) , Anneleen Decock (UGent) , Nitin Patil, et al.

(2016) ONCOTARGET. 7(41). p.66344-66359

1
2
3
4
5
6

Next →